One step closer to a cure for preeclampsia? Boosting the natural affinity of VEGF (vascular endothelial growth factor) to sFlt (soluble fms-like tyrosine kinase)-1

Benzer Materyaller

• The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
  Yazar:: Kifle, MM, ve diğerleri
  Baskı/Yayın Bilgisi: (2022)
• The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
  Yazar:: Meron M. Kifle, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-06-01)
• Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
  Yazar:: Natalie J. Hannan, ve diğerleri
  Baskı/Yayın Bilgisi: (2017-05-01)
• Differences in levelFms-Like Tyrosine Kinase-1 (sFlt-1), soluble Endoglin (s-Eng), and Placental Growth Factor (PIGF) between Early Onset Preeclampsia and Late Onset Preeclampsia
  Yazar:: Lita Nafratilova, ve diğerleri
  Baskı/Yayın Bilgisi: (2018-10-01)
• The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience
  Yazar:: Andrijana Müller, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-02-01)